O-143 Gemcitabine-oxaliplatin (GEMOX) chemotherapy as first-line treatment in advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II study

Lucio Crino, Silvia Novello, Filippo De Marinis, Michela Maur, Giorgio Scagliotti, S. Salvagni, E. Crucitta, Antonio Maestri, Stefania Bartolini, Federico Cappuzzo
  • Lung Cancer, August 2003, Elsevier
  • DOI: 10.1016/s0169-5002(03)91801-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo